The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.

MLA

Franzen, Carrie A., et al. “The Chemopreventive Bioflavonoid Apigenin Inhibits Prostate Cancer Cell Motility through the Focal Adhesion Kinase/Src Signaling Mechanism.” Cancer Prevention Research (Philadelphia, Pa.), vol. 2, no. 9, Sept. 2009, pp. 830–41. EBSCOhost, https://doi.org/10.1158/1940-6207.CAPR-09-0066.

APA

Franzen, C. A., Amargo, E., Todorović, V., Desai, B. V., Huda, S., Mirzoeva, S., Chiu, K., Grzybowski, B. A., Chew, T.-L., Green, K. J., & Pelling, J. C. (2009). The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prevention Research (Philadelphia, Pa.), 2(9), 830–841. https://doi.org/10.1158/1940-6207.CAPR-09-0066

Chicago

Franzen, Carrie A, Evangeline Amargo, Viktor Todorović, Bhushan V Desai, Sabil Huda, Salida Mirzoeva, Karen Chiu, et al. 2009. “The Chemopreventive Bioflavonoid Apigenin Inhibits Prostate Cancer Cell Motility through the Focal Adhesion Kinase/Src Signaling Mechanism.” Cancer Prevention Research (Philadelphia, Pa.) 2 (9): 830–41. doi:10.1158/1940-6207.CAPR-09-0066.